We are live on ! Find out more
WF

Welch & Forbes Portfolio holdings

AUM $8.23B
1-Year Est. Return 17.62%
This Fund
S&P 500
This Quarter Est. Return
-4.79%
1 Year Est. Return
+17.62%
3 Year Est. Return
+73.71%
5 Year Est. Return
+105.59%
10 Year Est. Return
+384.92%
AUM
$5.12B
AUM Growth
-$345M
Cap. Flow
-$36.9M
Cap. Flow %
-0.72%
Top 10 Hldgs %
29.77%
Holding
386
New
7
Increased
134
Reduced
131
Closed
16

Top Buys

Rank Stock Value
1
AOS icon
A.O. Smith
AOS
+$3.37M
2
AAPL icon
Apple
AAPL
+$1.98M
3
AMZN icon
Amazon
AMZN
+$1.74M
4
NEE icon
NextEra Energy
NEE
+$1.7M
5
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$1.56M

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$28.4M
2
BALL icon
Ball Corp
BALL
+$4.2M
3
META icon
Meta Platforms (Facebook)
META
+$3.17M
4
INTC icon
Intel
INTC
+$2.2M
5
PFF icon
iShares Preferred and Income Securities ETF
PFF
+$2.04M

Sector Composition

Rank Sector Weight
1 Technology 21.09%
2 Healthcare 20.53%
3 Consumer Discretionary 12.15%
4 Financials 11.63%
5 Consumer Staples 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABT icon
26
Abbott
ABT
$183B
$62.8M 1.23%
649,183
+3,596
+0.6% +$383K
IDXX icon
27
Idexx Laboratories
IDXX
$44.1B
$58.2M 1.14%
178,531
-471
-0.3% -$173K
ADP icon
28
Automatic Data Processing
ADP
$105B
$58M 1.13%
256,455
-4,136
-2% -$976K
WSO icon
29
Watsco Inc
WSO
$12.8B
$56.2M 1.1%
218,424
+2,763
+1% +$749K
ABBV icon
30
AbbVie
ABBV
$455B
$55.5M 1.08%
413,621
-1,399
-0.3% -$201K
VRTX icon
31
Vertex Pharmaceuticals
VRTX
$122B
$54.9M 1.07%
189,458
-2,775
-1% -$798K
CVX icon
32
Chevron
CVX
$383B
$53.6M 1.05%
372,849
+3,836
+1% +$585K
AMP icon
33
Ameriprise Financial
AMP
$48.1B
$52.9M 1.03%
210,122
+366
+0.2% +$96.3K
AJG icon
34
Arthur J. Gallagher & Co
AJG
$65.9B
$50.9M 0.99%
297,130
+890
+0.3% +$158K
AMZN icon
35
Amazon
AMZN
$2.53T
$50.2M 0.98%
444,023
+13,766
+3% +$1.74M
TJX icon
36
TJX Companies
TJX
$176B
$49.6M 0.97%
798,719
-4,319
-0.5% -$271K
PAYX icon
37
Paychex
PAYX
$41.4B
$49.2M 0.96%
438,042
-5,267
-1% -$653K
GOOGL icon
38
Alphabet (Google) Class A
GOOGL
$4.08T
$44.7M 0.87%
467,806
-2,674
-0.6% -$297K
TMO icon
39
Thermo Fisher Scientific
TMO
$214B
$41.3M 0.81%
81,376
+758
+0.9% +$424K
LLY icon
40
Eli Lilly
LLY
$1.03T
$39.3M 0.77%
121,594
-2,596
-2% -$823K
CMCSA icon
41
Comcast
CMCSA
$84B
$38.8M 0.76%
1,322,861
+10,905
+0.8% +$408K
BRK.B icon
42
Berkshire Hathaway Class B
BRK.B
$1.1T
$35.8M 0.7%
133,892
+1,436
+1% +$409K
MRK icon
43
Merck
MRK
$321B
$34.9M 0.68%
405,119
+2,848
+0.7% +$254K
BAC icon
44
Bank of America
BAC
$433B
$34.8M 0.68%
1,150,652
+5,419
+0.5% +$181K
IRM icon
45
Iron Mountain
IRM
$37.1B
$32.5M 0.63%
738,058
-991
-0.1% -$50K
CHD icon
46
Church & Dwight Co
CHD
$23.1B
$31.8M 0.62%
445,284
+511
+0.1% +$44.1K
PFF icon
47
iShares Preferred and Income Securities ETF
PFF
$13.3B
$30.4M 0.59%
961,486
-60,871
-6% -$2.04M
XOM icon
48
ExxonMobil
XOM
$651B
$29.4M 0.57%
336,564
+5,220
+2% +$477K
EMLP icon
49
First Trust North American Energy Infrastructure Fund
EMLP
$4.09B
$29.1M 0.57%
1,168,345
-13,488
-1% -$367K
VZ icon
50
Verizon
VZ
$193B
$28.7M 0.56%
757,057
+17,898
+2% +$797K
1
2
3 4 5

Similar funds

OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
LGF
LGT Group Foundation Vaduz, Liechtenstein $8.19B AUM 27.7% 1-Year Est. Return
CCM
Causeway Capital Management Los Angeles, California $8.15B AUM 29.28% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $8.15B AUM 20.12% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return

Welch & Forbes's Q3 2022 Portfolio in Review

As of Q3 2022, Welch & Forbes held 386 positions worth $5.12B, down 6.3% from $5.47B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Welch & Forbes's Q3 2022 filing shows 7 new, 134 increased, 131 reduced and 16 closed positions. Its largest new stake was Vanguard High Dividend Yield ETF: 6,616 shares worth $628K. The largest sale was GSK, an estimated $28.4M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Welch & Forbes's largest Q3 2022 buy was Vanguard High Dividend Yield ETF: 6,616 shares worth $628K.
  • Welch & Forbes added most to A.O. Smith in Q3 2022, an estimated $3.37M increase.
  • Welch & Forbes's biggest Q3 2022 reduction was Ball Corp, cutting an estimated $4.2M.
  • Welch & Forbes fully exited GSK in Q3 2022, selling an estimated $28.4M.
  • Welch & Forbes's ten largest holdings make up 30% of its $5.12B portfolio in Q3 2022.
  • Welch & Forbes opened 7 new positions and closed 16 in Q3 2022.
  • Welch & Forbes's portfolio value fell 6.3% quarter-over-quarter to $5.12B.

Based on Welch & Forbes's 13F filing for Q3 2022, filed 31 Oct 2022.